Author

Peluso M

University of California, San Francisco - Cited by 5,847

Biography

He is  an infectious disease clinical-translational physician-scientist. His primary interests are HIV and COVID-19. he nvolved with clinical and laboratory research aimed at understanding the HIV reservoir and implementing clinical trials to disrupt the reservoir with the aim of inducing antiretroviral therapy-free HIV remission. In addition, he  manage a large observational study of people who previously had SARS-CoV-2 infection with the goal of understanding the long-term biological and immunological consequences of COVID-19.
Title
Cited by
Year
Use of cardiopulmonary exercise testing to evaluate long COVID-19 symptoms in adults: a systematic review and meta-analysis
MS Durstenfeld, K Sun, P Tahir, MJ Peluso, SG Deeks, MA Aras, ...JAMA network open 5 (10), e2236057-e2236057, 2022202
38
2022
Chronic viral coinfections differentially affect the likelihood of developing long COVID
MJ Peluso, TM Deveau, SE Munter, D Ryder, A Buck, G Beck-Engeser, ...The Journal of Clinical Investigation 133 (3), 2023202
29
2023
Postacute sequelae and adaptive immune responses in people with HIV recovering from SARS-COV-2 infection
MJ Peluso, MA Spinelli, TM Deveau, CA Forman, SE Munter, S Mathur, ...Aids 36 (12), F7-F16, 2022202
28
2022
Plasma markers of neurologic injury and inflammation in people with self-reported neurologic postacute sequelae of SARS-CoV-2 infection
MJ Peluso, HM Sans, CA Forman, AN Nylander, H Ho, S Lu, SA Goldberg, ...Neurology-Neuroimmunology Neuroinflammation 9 (5), 2022202
16
2022
Infectious viral shedding of SARS-CoV-2 Delta following vaccination: a longitudinal cohort study
M Garcia-Knight, K Anglin, M Tassetto, S Lu, A Zhang, SA Goldberg, ...PLoS Pathogens 18 (9), e1010802, 2022202
16
2022
Factors associated with long COVID symptoms in an online cohort study
MS Durstenfeld, MJ Peluso, ND Peyser, F Lin, SJ Knight, A Djibo, ...Open forum infectious diseases 10 (2), ofad047, 2023202
11
2023
Detection of Higher Cycle Threshold Values in Culturable SARS-CoV-2 Omicron BA. 1 Sublineage Compared with Pre-Omicron Variant Specimens—San Francisco Bay Area, California …
M Tassetto, M Garcia-Knight, K Anglin, S Lu, A Zhang, M Romero, ...Morbidity and Mortality Weekly Report 71 (36), 1151, 2022202
10
2022
Low prevalence of interferon α autoantibodies in people experiencing symptoms of post–coronavirus disease 2019 (COVID-19) conditions, or long COVID
MJ Peluso, A Mitchell, CY Wang, S Takahashi, R Hoh, V Tai, ...The Journal of infectious diseases 227 (2), 246-250, 2023202
10
2023
Development of a definition of postacute sequelae of SARS-CoV-2 infection
T Thaweethai, SE Jolley, EW Karlson, EB Levitan, B Levy, GA McComsey, ...Jama 329 (22), 1934-1946, 2023202
8
2023
Magnitude and determinants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) household transmission: a longitudinal cohort study
JD Kelly, S Lu, K Anglin, M Garcia-Knight, J Pineda-Ramirez, ...Clinical Infectious Diseases 75 (Supplement_2), S193-S204, 20228202
8
2022
Progressive transformation of the HIV-1 reservoir cell profile over two decades of antiviral therapy
X Lian, KW Seiger, EM Parsons, C Gao, W Sun, GT Gladkov, IC Roseto, ...Cell Host & Microbe 31 (1), 83-9. e5, 2023202
6
2023
Long COVID manifests with T cell dysregulation, inflammation, and an uncoordinated adaptive immune response to SARS-CoV-2
K Yin, MJ Peluso, R Thomas, MG Shin, J Neidleman, X Luo, R Hoh, ...bioRxiv, 2023.02. 09.27892, 2023202
5
2023
Evaluation of severe acute respiratory syndrome coronavirus 2 nucleocapsid antigen in the blood as a diagnostic test for infection and infectious viral shedding
S Mathur, MC Davidson, K Anglin, S Lu, SA Goldberg, M Garcia-Knight, ...Open Forum Infectious Diseases 9 (11), ofac56, 2022202
3
2022
Autoantigen profiling reveals a shared post-COVID signature in fully recovered and Long COVID patients
A Bodansky, CY Wang, A Saxena, A Mitchell, S Takahashi, K Anglin, ...medRxiv, 03.0. 06.38553, 030
2
2023
Critical considerations for public engagement in stem cell-related research
J Sugarman, A Clark, J Fishkin, K Kato, K McCormack, M Munsie, ...Stem Cell Reports 18 (), 40-46, 030
2
2023
Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative
H Bonilla, MJ Peluso, K Rodgers, JA Aberg, TF Patterson, R Tamburro, ...Frontiers in immunology 14, 119459, 030
2
2023
Association of Nirmatrelvir/Ritonavir Treatment with Long COVID Symptoms in an Online Cohort of Non-Hospitalized Individuals Experiencing Breakthrough SARS-CoV-2 Infection in …
MS Durstenfeld, MJ Peluso, F Lin, ND Peyser, C Isasi, TW Carton, ...medRxiv, 2023.03. 02.23286730, 2023202
1
2023
Ethical and practical considerations for cell and gene therapy toward an HIV cure: findings from a qualitative in-depth interview study in the United States
K Dubé, J Kanazawa, H Patel, M Louella, L Sylla, J Sheehy, L Dee, ...BMC Medical Ethics 23 (), -7, 2022202
1
2022
Novel approaches in the treatment of Hansen’s disease (Leprosy): a case series of multidrug therapy of monthly rifampin, moxifloxacin, and minocycline (RMM) in the United States
C Franco-Paredes, E Garcia-Creighton, A Henao-Martínez, DL Kallgren, ...Therapeutic advances in infectious disease 9, 20499362235885, 2022202
1
2022
SARS-CoV-2 Serology Across Scales: A Framework for Unbiased Estimation of Cumulative Incidence Incorporating Antibody Kinetics and Epidemic Recency
S Takahashi, MJ Peluso, J Hakim, K Turcios, O Janson, I Routledge, ...American Journal of Epidemiology, kwad06, 2023202
1
2023

Referred From: https://scholar.google.com/citations?user=vejnOn8AAAAJ&hl=en

Cited by
Citations 5847
h-index 30
i10-index 68
Recommended Journals
Open Access Journals